HEPATOCELLULAR CANCER
Clinical trials for HEPATOCELLULAR CANCER explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CANCER trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Terminated trial tested unusual drug mix for tough liver cancers
Disease control TerminatedThis study tested whether combining three existing drugs—nivolumab (an immunotherapy), tadalafil (a blood pressure/erectile dysfunction drug), and oral vancomycin (an antibiotic)—could shrink advanced liver cancers. It was for adults whose liver cancer (either starting in the liv…
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New cancer drug trial tests immune system booster for tough tumors
Disease control TerminatedThis study tested a new drug called TAK-500, designed to activate the immune system to fight cancer. It was given alone or combined with an existing immunotherapy drug (pembrolizumab) to adults with advanced solid tumors that had stopped responding to standard treatments. The mai…
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Network aims to match cancer patients to treatments based on their Tumor's DNA
Knowledge-focused TerminatedThis study aimed to create a network and database to improve personalized treatment for people with advanced gastrointestinal cancers. It involved collecting and analyzing the genetic profiles of patients' tumors to see if they had specific mutations that could be targeted by exi…
Matched conditions: HEPATOCELLULAR CANCER
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC